Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949611 · ClinicalTrials.gov registry record · NA
Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT00949611: Completed NA study, sponsored by Mayo Clinic.
NCT00949611 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00949611, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making approach with patients, allowing the clinician and patient to weigh potential fracture risk (without treatment), versus risk reduction with medication (including side effects and costs). OSTEOPOROSIS CHOICE II will test the effectiveness of: * FRAX * FRAX + decision aid * Usual care (no decision aid and no FRAX given to clinician)
Interventions
- BEHAVIORAL FRAX + Decision Aid
- BEHAVIORAL FRAX estimated fracture risk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00949611
The ClinicalTrials.gov registry entry for NCT00949611 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FRAX + Decision Aid is the first listed.
NCT00949611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00949611 about?
NCT00949611 is a clinical study titled "Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians". Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making a...
What is the current status of trial NCT00949611?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2009-05. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00949611?
The interventions under investigation include: FRAX + Decision Aid (BEHAVIORAL), FRAX estimated fracture risk (BEHAVIORAL).
Who is sponsoring clinical trial NCT00949611?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.